Boosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions.

Basic & Clinical Pharmacology & Toxicology
Eric D EisenmannSharyn D Baker

Abstract

Oral anticancer drugs suffer from significant variability in pharmacokinetics and pharmacodynamics partially due to limited bioavailability. The limited bioavailability of anticancer drugs is due to both pharmaceutical limitations and physiological barriers. Pharmacokinetic boosting is a strategy to enhance the oral bioavailability of a therapeutic drug by inhibiting physiological barriers through an intentional drug-drug interaction (DDI). This type of strategy has proven effective across several therapeutic indications including anticancer treatment. Pharmacokinetic boosting could improve anticancer drugs lacking or with otherwise unacceptable oral formulations through logistic, economic, pharmacodynamic and pharmacokinetic benefits. Despite these benefits, pharmacokinetic boosting strategies could result in unintended DDIs and are only likely to benefit a limited number of targets. Highlighting this concern, pharmacokinetic boosting has mixed results depending on the boosted drug. While pharmacokinetic boosting did not significantly improve certain drugs, it has resulted in the commercial approval of boosted oral formulations for other drugs. Pharmacokinetic boosting to improve oral anticancer therapy is an expanding area of...Continue Reading

References

Dec 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S D BakerE K Rowinsky
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G LiuE Warner
Oct 3, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J NemunaitisR Pazdur
Nov 18, 2000·Investigational New Drugs·S D Baker
Feb 22, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M M MalingréJ H Schellens
Dec 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A SparreboomJ Verweij
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex A AdjeiCharles Erlichman
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary Hudes
Jun 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C M F KruijtzerJ H M Schellens
Oct 22, 2002·European Journal of Clinical Pharmacology·Stefanie ReifHoward L McLeod
Oct 31, 2002·Advanced Drug Delivery Reviews·Jatinder K LambaKenneth E Thummel
Jan 7, 2004·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Lauretta M S ChanBarry H Hirst
May 14, 2004·Clinical Pharmacokinetics·Giuseppe ToffoliMauro Boiocchi
Aug 19, 2004·Cancer Chemotherapy and Pharmacology·I E L M KuppensJ H M Schellens
Feb 20, 2007·Cancer Chemotherapy and Pharmacology·Wei Peng YongMark J Ratain
Mar 3, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·K Le LayR Launois
May 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John R EckardtGraham Ross
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark J Ratain, Ezra E Cohen
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roos L OostendorpJan H M Schellens
Jun 24, 2010·Cancer Treatment Reviews·Giuseppe Luigi BannaFrancesco Ferraù
Feb 20, 2013·Clinical Pharmacokinetics·Frederik E StuurmanJan H M Schellens
Mar 9, 2013·Pharmacotherapy·Bhavik M ShahKathleen E Squires
Jan 1, 2010·Cancers·Koh MiuraIwao Sasaki
Jun 4, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Angelo PaciEtienne Chatelut
Jun 15, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nicolas WidmerAlain Astier
Sep 12, 2014·Journal of Pharmacology & Pharmacotherapeutics·Rituparna Maiti
Mar 31, 2015·Cancer Treatment Reviews·Maikel HerbrinkJos H Beijnen
Jul 15, 2015·Pharmacology Research & Perspectives·Jan de JongErik Mannaert
Aug 25, 2015·International Journal of Cancer. Journal International Du Cancer·Jeroen J M A HendrikxAlfred H Schinkel
Oct 16, 2015·The Oncologist·Christopher R CogleGuillermo Garcia-Manero
Feb 10, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roelof W F van LeeuwenRon H J Mathijssen
Mar 8, 2016·Expert Opinion on Drug Metabolism & Toxicology·Nicolas HohmannGerd Mikus
Mar 21, 2016·Drug Discovery Today·Annelieke E C A B WillemsenNielka P van Erp
Aug 29, 2016·Drugs·Celeste B Burness, Sean T Duggan
Apr 8, 2017·Acta Oncologica·Floor J E LubbermanCarla M L van Herpen
Sep 29, 2018·Scientia pharmaceutica·Jürgen Krauß, Franz Bracher
Mar 29, 2019·Journal of Cellular and Molecular Medicine·Meng SuGabriel Ghiaur

❮ Previous
Next ❯

Citations

Nov 26, 2021·Basic & Clinical Pharmacology & Toxicology·Anton Pottegård, Tore B Stage

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Rehab Management
F J Fowler
Sports Health
Edward M Wojtys
British Dental Journal
I O Otohwo, D R Sadoh
© 2021 Meta ULC. All rights reserved